Keywords: avandia, withdrawals, increase, accelerate, tns, report, july
Avandia withdrawals increase and accelerate; TNS report
Article | 19 November 2007
From July through September of this year, nearly 70% of changes in the prescribing of UK-headquartered drug giant GlaxoSmithKline's antidiabetic product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
